Biblio

Motte-Baumvol B, Bonin O, Nassi CDavid, Belton-Chevallier L.  2016.  Barriers and (im)mobility in Rio de Janeiro. URBAN STUDIES. 53:2956-2972.

Mazellier S, Ramanah R, Guldenfels C, Mathelin C.  2022.  Barriers to breast cancer screening for people with disabilities. BULLETIN DU CANCER. 109:185-196.

Prod'homme C, Jacquemin D, Touzet L, Aubry R, Daneault S, Knoops L.  2018.  Barriers to end-of-life discussions among hematologists: A qualitative study. PALLIATIVE MEDICINE. 32:1021-1029.

Joussain C., Joubert J., Laroche D., D'Antono B., Juneau M., Gremeaux V..  2017.  Barriers to physical activity in coronary artery disease patients: Development and validation of a new scale. ANNALS OF PHYSICAL AND REHABILITATION MEDICINE. 60:289-298.

Neyraud E, Cabaret S, Brignot H, Chabanet C, Laboure H, Guichard E, Berdeaux O.  2017.  The basal free fatty acid concentration in human saliva is related to salivary lipolytic activity. SCIENTIFIC REPORTS. 7:5969.

Barbier M, Chometton S, Pautrat A, Miguet-Alfonsi C, Datiche F, Gascuel J, Fellmann D, Peterschmitt Y, Coizet V, Risold P-Y.  2020.  A basal ganglia-like cortical-amygdalar-hypothalamic network mediates feeding behavior. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 117:15967-15976.

Baronio F, Chen S, Grelu P, Wabnitz S, Conforti M.  2015.  Baseband modulation instability as the origin of rogue waves. PHYSICAL REVIEW A. 91:033804.

Martel-Pelletier J., Teichtahl A.J, Cicuttini FM, Wang Y., Abram F., Pelletier J.-P.  2016.  BASELINE AND PERSISTENT KNEE SYMPTOMS ARE INDEPENDENT PREDICTORS OF STRUCTURAL PROGRESSION OF KNEE OSTEOARTHRITIS. OSTEOPOROSIS INTERNATIONAL. 27:S52.

Chopard R, Teiger E, Meneveau N, Chocron S, Gilard M, Laskar M, Eltchaninoff H, Iung B, Leprince P, Chevreul K et al..  2015.  Baseline Characteristics and Prognostic Implications of Pre-Existing and New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Implantation Results From the FRANCE-2 Registry. JACC-CARDIOVASCULAR INTERVENTIONS. 8:1346-1355.

Blanco-Garavito R, Oubraham H, Wolff B, Cohen SY, Garcher CP, Korobelnik J-F, Delhay C, Tadayoni R, Derveloy A, Souied EH et al..  2015.  Baseline characteristics of French patients with wet age-related macular degeneration(wAMD) enrolled in the LUMINOUS study. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 56

Blanco-Garavito R, Oubraham H, Wolff B, Cohen SY, Garcher CP, Korobelnik J-F, Delhay C, Tadayoni R, Derveloy A, Souied EH et al..  2015.  Baseline characteristics of French patients with wet age-related macular degeneration(wAMD) enrolled in the LUMINOUS study. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 56

Anker SD, Butler J, Filippatos G, Khan MShahzeb, Ferreira JPedro, Bocchi E, Bohm M, La Rocca HPieter Bru, Choi D-J, Chopra V et al..  2020.  Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial. EUROPEAN JOURNAL OF HEART FAILURE. 22:2383-2392.

Saraux A., Flipo R.-M, Fagnani F., Bru I., Cukierman G., Joubert J.-M, Czarlewski W., Dunkel J., Massol J., Combe B..  2015.  BASELINE CHARACTERISTICS OF RHEUMATOID ARTHRITIS PATIENTS STARTING CERTOLIZUMAB PEGOL THERAPY AND GLUCOCORTICOID PRESCRIPTION IN THE ECLAIR STUDY IN 2012-2013. ANNALS OF THE RHEUMATIC DISEASES. 74:1269.

Saraux A., Flipo R., Fagnani F., Bru I, Cukierman G., Joubert J., Czarlewski W., Dunkel J., Massol J., Combe B..  2015.  BASELINE CHARACTERISTICS OF RHEUMATOID ARTHRITIS PATIENTS STARTING CERTOLIZUMAB PEGOL THERAPY AND GLUCOCORTICOID PRESCRIPTION IN THE ECLAIR STUDY IN 2012-2013. VALUE IN HEALTH. 18:A637.

Meignan M, Cottereau ASegolene, Versari A, Chartier L, Dupuis J, Boussetta S, Grassi I, Casasnovas R-O, Haioun C, Tilly H et al..  2016.  Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies. JOURNAL OF CLINICAL ONCOLOGY. 34:3618+.

Kanoun S, Rossi C, Berriolo-Riedinger A, Dygai-Cochet I, Cochet A, Humbert O, Toubeau M, Ferrant E, Brunotte F, Casasnovas R-O.  2014.  Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 41:1735-1743.

Meignan M, Versari A, Cottereau ASegolene, Chartier L, Dupuis J, Boussetta S, Grassi I, Casasnovas R-O, Haioun C, Tilly H et al..  2015.  Baseline Metabolic Tumour Volume Predicts Outcome in High Tumor Burden Follicular Lymphoma. A Pooled Analysis of Three Multicenter Studies. BLOOD. 126

Busch C, Okada M, Zur D, Fraser-Bell S, Rodriguez-Valdes PJ, Cebeci Z, Lupidi M, Fung AT, Gabrielle P-H, Giancipoli E et al..  2020.  Baseline predictors for visual acuity loss during observation in diabetic macular oedema with good baseline visual acuity. ACTA OPHTHALMOLOGICA. 98:E801-E806.

Licaj I., Dabakuyo S., Dauchy S., I. Luis V, Charles C., Lemogne C., Tredan O., Vanlemmens L., Jouannaud C., Levy C. et al..  2019.  Baseline quality of life (QoL) and chemotherapy related toxicities (CRT) in localized breast cancer (BC) patients (pts): The French multicentric prospective CANTO cohort study. ANNALS OF ONCOLOGY. 30

Niogret J, Limagne E, Thibaudin M, Blanc J, Bertaut A, Le Malicot K, Rinaldi Y, Caroli-Bosc F-X, Audemar F, Nguyen S et al..  2020.  Baseline Splenic Volume as a Prognostic Biomarker of FOLFIRI Efficacy and a Surrogate Marker of MDSC Accumulation in Metastatic Colorectal Carcinoma. CANCERS. 12:1429.

Rossi C, Tosolini M, Gravelle P, Pericart S, Kanoun S, Evrard S, Gilhodes J, Franchini D-M, Amara N, Syrykh C et al..  2022.  Baseline SUVmax is related to tumor cell proliferation and patient outcome in follicular lymphoma. HAEMATOLOGICA. 107:221-230.

Cottereau A-S, Hapdey S, Chartier L, Modzelewski R, Casasnovas O, Itti E, Tilly H, Vera P, Meignan MA, Becker S.  2017.  Baseline Total Metabolic Tumor Volume Measured with Fixed or Different Adaptive Thresholding Methods Equally Predicts Outcome in Peripheral T Cell Lymphoma. JOURNAL OF NUCLEAR MEDICINE. 58:276-281.

Cottereau ASegolene, Hapdey S, Modzelewski R, Gardin I, Itti E, Casasnovas O, Tilly HA, Vera P, Meignan M, Becker S.  2016.  Baseline Total Metabolic Tumour Volume measured with fixed or different adaptive thresholding methods equally predicts outcome in Peripheral T cell lymphoma.. JOURNAL OF NUCLEAR MEDICINE. 57

Cottereau ASegolene, Hapdey S, Modzelewski R, Gardin I, Itti E, Casasnovas O, Tilly HA, Vera P, Meignan M, Becker S.  2016.  Baseline Total Metabolic Tumour Volume measured with fixed or different adaptive thresholding methods equally predicts outcome in Peripheral T cell lymphoma.. JOURNAL OF NUCLEAR MEDICINE. 57

Casasnovas O., Kanoun S., Tal I., Cottereau A.S, Edeline V., Brice P., Bouabdallah R., Salles G., Stamatoullas A., Dupuis J. et al..  2016.  BASELINE TOTAL METABOLIC VOLUME (TMTV) PREDICTS THE OUTCOME OF PATIENTS WITH ADVANCED HODGKIN LYMPHOMA (HL) ENROLLED IN THE AHL2011 LYSA TRIAL. HAEMATOLOGICA. 101:4.